ライフサイエンスコーパス: assisted reproductive technology

1 matured in vitro to produce spermatozoa for assisted reproductive technology.

2 ryo vitrification is a standard procedure in assisted reproductive technology.

3 ility as time to pregnancy >=12 mo or use of assisted reproductive technology.

4 rance coverage of fertility preservation and assisted reproductive technology.

5 rance coverage of fertility preservation and assisted reproductive technology.

6 maintenance of anisogamy and for outcomes of assisted reproductive technology.

7 e potential or decrease the need for complex assisted reproductive technology.

8 physiology may affect the outcomes of modern assisted reproductive technology.

9 ultiple gestations resulting from the use of assisted reproductive technology.

10 ce patterns and in outcomes after the use of assisted reproductive technology.

11 ul genetic counseling of couples who opt for assisted reproductive technology.

12 en a growing focus on spermatozoa sorting in assisted reproductive technology.

13 man fertility and infertility, and improving assisted reproductive technologies.

14 eing developed to increase the efficiency of assisted reproductive technologies.

15 interactions, with potential applications in assisted reproductive technologies.

16 ese associations were modified by the use of assisted reproductive technologies.

17 his period and could lead to improvements in assisted reproductive technologies.

18 labour induction and caesarean delivery and assisted reproductive technologies.

19 rity, fluidity, and stability to advance the assisted reproductive technologies.

20 le throughout the world are permitted to use assisted reproductive technologies.

21 problem during infertility treatments using assisted reproductive technologies.

22 decreasing multiple embryo transfers during assisted reproductive technologies (0.06), cervical cerc

23 .7%]; P < .001), and were more likely to use assisted reproductive technology (172 of 692 [24.9%] vs

24 Infants conceived with assisted reproductive technology accounted for 0.6 perce

25 The use of assisted reproductive technology accounts for a dispropo

26 maternal age, BMI, gravidity, parity, use of assisted reproductive technology, adverse obstetric hist

27 ected prevalence of monozygotic twinning, of assisted reproductive technology among parents, and of d

28 tation development is a gateway to improving assisted reproductive technologies and stem cell researc

29 0, to August 23, 2021, using the Society for Assisted Reproductive Technology and BabyCenter, an onli

30 o evaluate whether pregnancies conceived via assisted reproductive technology and exposed to Hurrican

31 authors conducted a validation study of the assisted reproductive technology and infertility drug us

32 ere born in 1996 and 1997 and conceived with assisted reproductive technology and used as a compariso

33 ts in normal imprinting are found in cancer, assisted reproductive technologies, and several human sy

34 rine surgery, induction of pregnancy through assisted reproductive technology, and any concurrently o

35 on delayed childbearing, infertility, use of assisted reproductive technology, and career alterations

36 record of infertility but no treatment with assisted reproductive technology, and pregnancies in wom

37 g pregnancy of more than 12 months or use of assisted reproductive technology; and miscarriage, defin

38 g pregnancy of more than 12 months or use of assisted reproductive technology; and miscarriage, defin

39 lications of this observation for the use of assisted reproductive technologies are especially releva

40 Pregnancies resulting from assisted reproductive technology are associated with an

41 Assisted reproductive technologies (ART) are associated

42 Assisted reproductive technologies (ART) are increasingl

43 Clomiphene and assisted reproductive technologies (ART) are methods use

44 Assisted reproductive technologies (ART) are not yet sys

45 tter that is of utmost concern for improving assisted reproductive technologies (ART) because low-fit

46 Assisted reproductive technologies (ART) can address inf

47 Embryos generated with the use of assisted reproductive technologies (ART) can develop ove

48 Children conceived by assisted reproductive technologies (ART) display a level

49 number of children born since the origin of Assisted Reproductive Technologies (ART) exceeds 5 milli

50 A key factor in the use of assisted reproductive technologies (ART) for diverse spe

51 The use of assisted reproductive technologies (ART) has become incr

52 both intrauterine insemination and in vitro assisted reproductive technologies (ART) procedures perf

53 conservation breeding programs often rely on assisted reproductive technologies (ART) to produce offs

54 Many procedures used in assisted reproductive technologies (ART) to treat human

55 tion (IVF) is one of the most highly pursued assisted reproductive technologies (ART) worldwide.

56 ugh their infertility is often bypassed with assisted reproductive technologies (ART), some accompani

57 Advances in assisted reproductive technologies (ART), specifically s

58 this method holds significant potential for assisted reproductive technologies (ART), where metaboli

59 ons of phthalate metabolites and outcomes of assisted reproductive technologies (ART).

60 15) versus never smokers (N = 44) undergoing assisted reproductive technologies (ART).

61 n (IVF) is the most widely used technique in assisted reproductive technologies (ART).

62 ryo quality provides significant advances in Assisted Reproductive Technologies (ART).

63 Given the relatively low success rates of assisted reproductive technologies (ART; ~25%), additive

64 recent observations suggests a link between assisted reproductive technology (ART) and epigenetic er

65 n development has important implications for assisted reproductive technology (ART) and for human emb

66 sing percentage of births are conceived with assisted reproductive technology (ART) and other inferti

67 Whether pregnancies conceived through assisted reproductive technology (ART) are at an increas

68 The methods of gamete manipulation used in assisted reproductive technology (ART) are rapidly proli

69 As assisted reproductive technology (ART) becomes increasin

70 In the past 25 years, the frequency of assisted reproductive technology (ART) births has increa

71 To examine associations of assisted reproductive technology (ART) conception (vs.

72 le partners (median age: 35 y) underwent 437 assisted reproductive technology (ART) cycles for infert

73 e that endogenously elevated estrogen during assisted reproductive technology (ART) exhibits little a

74 ernal age (AMA, >=35 years) women undergoing assisted reproductive technology (ART) face reduced live

75 Use of assisted reproductive technology (ART) has been associat

76 e number of children born through the use of assisted reproductive technology (ART) has been increasi

77 In recent decades, the use of assisted reproductive technology (ART) has increased rap

78 The increasing use of assisted reproductive technology (ART) has raised concer

79 s known about the outcomes of pregnancy with assisted reproductive technology (ART) in women with kid

80 Assisted reproductive technology (ART) involves the mani

81 The use of assisted reproductive technology (ART) is growing, both

82 Assisted reproductive technology (ART) may affect fetal

83 Patients using assisted reproductive technology (ART) may need addition

84 cent data in humans and animals suggest that assisted reproductive technology (ART) might affect the

85 Assisted reproductive technology (ART) refers to process

86 lantation failure (IF) in couples undergoing Assisted Reproductive Technology (ART) treatment.

87 in both natural pregnancies and those after assisted reproductive technology (ART) treatment.

88 Data on live births, assisted reproductive technology (ART) use, and mortalit

89 to investigate 1) whether the association of assisted reproductive technology (ART) with preterm birt

90 ytoplasmic sperm injection (ICSI), a type of assisted reproductive technology (ART), can induce epimu

91 rm injection (ICSI), the most common type of assisted reproductive technology (ART), might damage the

92 In assisted reproductive technology (ART), predictive model

93 tational diabetes, gestational hypertension, assisted reproductive technology (ART), rates of materna

94 men with obesity are also more likely to use assisted reproductive technology (ART), which frequently

95 ir pollution and livebirth among women using assisted reproductive technology (ART).

96 years of fertility and may begin to turn to assisted reproductive technologies (ARTs) and egg donati

97 nts that include ovulation stimulation, both assisted reproductive technologies (ARTs) and non-ART ov

98 The association between assisted reproductive technologies (ARTs) and the body m

99 Although widely used, assisted reproductive technologies (ARTs) are associated

100 rm cells directly from raw semen samples for assisted reproductive technologies (ARTs) as an alternat

101 Assisted reproductive technologies (ARTs) have been show

102 Assisted reproductive technologies (ARTs) have now contr

103 During the past two decades, assisted reproductive technologies (ARTs) have revolutio

104 The efficiency of assisted reproductive technologies (ARTs) in nonhuman pr

105 The use of assisted reproductive technologies (ARTs) is steadily in

106 inting disorders in children conceived using assisted reproductive technologies (ARTs), and aberrant

107 vel, at high-throughput, would be useful for assisted reproductive technologies (ARTs), as it can all

108 embryo transfers reported to the Society for Assisted Reproductive Technology between 2014 and 2016.

109 enesis, hormonal cycles and the way in which assisted reproductive technologies can be applied, and k

110 d reproductive technology in the Society for Assisted Reproductive Technology Clinic Outcome Reportin

111 oocytes at member clinics of the Society for Assisted Reproductive Technology Clinic Outcomes Report

112 data from member clinics of the Society for Assisted Reproductive Technology Clinical Outcomes Repor

113 ly validated by linkage with the Society for Assisted Reproductive Technology-Clinical Outcome Report

114 S region, state FP mandate status, number of assisted reproductive technology cycles performed, and n

115 older, low oocyte yield, and 2 or more prior assisted reproductive technology cycles; reproductive ou

116 ty treatment (ie, intrauterine insemination, assisted reproductive technology, fertility preservation

117 edical indications and ethical acceptance of assisted reproductive technologies for adult-onset cance

118 e optimization of semen cryopreservation and assisted reproductive technologies for the critically en

119 national data collected from the Society for Assisted Reproductive Technology for 33 863 recipients u

120 ten million babies conceived globally, using assisted reproductive technologies, fundamental question

121 of gestation or later, those conceived with assisted reproductive technology had a risk of low birth

122 known, although recently an association with assisted reproductive technologies has been described.

123 low birth weight associated with the use of assisted reproductive technology has been attributed lar

124 of the few species, beside humans, in which assisted reproductive technology has important clinical

125 Live-birth rates after treatment with assisted reproductive technology have traditionally been

126 Assisted reproductive technologies in all mammals are cr

127 a novel means to improve the success rate of assisted reproductive technologies in fertility clinics.

128 We linked a census of treatment with assisted reproductive technology in South Australia to a

129 We linked data from cycles of assisted reproductive technology in the Society for Assi

130 [n = 41 628], and estrogen [n = 16 948]) and assisted reproductive technology (in vitro fertilization

131 ss other states and to understand why use of assisted reproductive technology is not a risk factor fo

132 iving versus deceased donation, (iii) use of assisted reproductive technologies, (iv) informed consen

133 singleton infants conceived with the use of assisted reproductive technology may also have a higher

134 e otherwise infertile men conceived using an assisted reproductive technology needs further evaluatio

135 d infertility, secondary infertility despite assisted reproductive technology, negative self-image, a

136 e differences in risk factors such as use of assisted reproductive technologies, obesity, smoking, an

137 mproved semen parameters, DNA integrity, and assisted reproductive technology outcomes after varicoce

138 tibodies are associated with infertility and assisted reproductive technology outcomes is unclear; al

139 ncluding the safety of contraception, use of assisted reproductive technology, preservation of fertil

140 We analyzed data on outcomes of assisted reproductive technology procedures as reported

141 PGT-M for monogenic PKD, like other forms of assisted reproductive technology, raises important ethic

142 We analyzed national data on assisted reproductive technology reported to the Centers

143 d data from the databases of the Society for Assisted Reproductive Technology (SART) in the US and th

144 These findings, captured by Society for Assisted Reproductive Technology (SART) national data, u

145 registry-based model produced by Society for Assisted Reproductive Technology (SART).

146 nancies in women who received treatment with assisted reproductive technology, spontaneous pregnancie

147 causes of infertility have been overcome by assisted reproductive technologies such as in vitro fert

148 n, and absence of sperm fertilising ability, assisted reproductive technologies, such as in-vitro fer

149 and ICSI cycles reported to the US National Assisted Reproductive Technology Surveillance System dur

150 Assisted reproductive technologies techniques are import

151 ertility is a significant health problem and assisted reproductive technologies to treat infertility.

152 We also profiled 25 healthy women undergoing assisted reproductive technology to monitor transcriptio

153 he rate of low birth weight after the use of assisted reproductive technology to the rate in the gene

154 Four physicians from two assisted reproductive technology treatment centers in th

155 Furthermore, in this era of assisted reproductive technologies, understanding the si

156 Assisted reproductive technology use does not appear to

157 Assisted reproductive technology use was previously vali

158 care, multiple pregnancy, placenta praevia, assisted reproductive technology use, macrosomia with a

159 of pregnancies occurred spontaneously, with assisted reproductive technologies used in the remaining

160 vitro fertilization (IVF) is the most common assisted reproductive technology used to treat infertili

161 al for in vitro gametogenesis to be used for assisted reproductive technologies using NWR iPSCs.

162 s data to evaluate trends in infertility and assisted reproductive technology utilization rates, incl

163 Assisted reproductive technology was associated with a l

164 The use of assisted reproductive technology was associated with an

165 Use of assisted reproductive technology was associated with dec

166 Assisted reproductive technology was associated with inc

167 Use of assisted reproductive technology was compared between ma

168 atural fecundity can be achieved by means of assisted reproductive technology when there are favorabl

169 igher levels of CCNA2 in patients undergoing assisted reproductive technology who had successful preg

170 es are more common among children born after assisted reproductive technology with fresh embryo trans

171 eight (<1500 g) among infants conceived with assisted reproductive technology with the rates in the g

172 antation remains a significant challenge for assisted reproductive technology, with implantation fail

173 infertility causes, childbearing decisions, assisted reproductive technology, workplace support, and